100% Quality Guarantee
PhD-Level Technical Support
Key Features

APC Anti-Human CD73 Antibody [AD2] (AGEL2490)

SKU AGEL2490
Product Type Antibody
Antibody Type Monoclonal Antibody
Applications FCM
Reactivity Human
Host Species Mouse
Isotype Mouse IgG1, κ
Clone AD2
Conjugation APC
$174 - $644

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

APC Anti-Human CD73 Antibody [AD2]

The APC Anti-Human CD73 Antibody (AD2) offered by Assay Genie is a powerful tool for researchers studying the CD73 cell surface molecule. CD73 plays a key role in immune regulation, particularly in the production of adenosine, which acts as a potent immunosuppressive molecule in the tumor microenvironment. This antibody, developed for use in flow cytometry and immunohistochemistry applications, is highly specific to human samples and enables the precise detection and analysis of CD73 expression in various cell types.CD73, also known as ecto-5'-nucleotidase, is involved in multiple biological processes, including inflammation, immune response modulation, and cancer progression.

By targeting CD73 with this antibody, researchers can explore its functions in immunology, oncology, and other fields, leading to a better understanding of its role in health and disease. The APC Anti-Human CD73 Antibody (AD2) holds great potential for advancing research in these areas and may contribute to the development of novel therapeutic strategies targeting CD73-mediated pathways.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose